Hospital Acquired Disease Testing Market to Benefit from Increasing Infection-Related Hospitalization, to Expand at 19.3% CAGR by 2019

Transparency Market Research Report Added "Hospital Acquired Disease Testing Market" to its database.

Logo

Albany, NY -- (SBWire) -- 10/28/2015 --Transparency Market Research (TMR) has released a new research report on the global hospital acquired disease testing market, which states that the said market will expand at a whopping 19.3% CAGR from 2013 to 2019. As such, the market with a valuation of US$2.2 bn in 2012 will be worth US$7.5 bn by 2019. The report, titled "Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", is available for sale on the company website.

Browse the full Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at http://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html

The market study offers an extensive analysis of the global hospital acquired disease testing market, which includes a comparative analysis of the past and present behavior of this market. The report also examines the growth prospects of this market in the coming years.The report states that the increasing prevalence of healthcare associated infections (HAIs) and resistance to drugs of an increasing number of pathogens are the primary factors driving the hospital acquired disease testing market.

In addition, the implementation of prevention codes by several governments around the world to keep a check on HAIs is furthering the growth of this market. Stringent regulations in place combined with expiration of PCR (pre-hospital care report) patents will aid growth of the hospital acquired disease testing market.However, the report states that in developing economies, inadequate funds, lack of skilled labor, and insufficient quality control mandates slow down the growth of this market.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1759

The global market for hospital acquired disease testing is divided on the basis of infection types and geography. By infection type, the market is segmented into urinary tract infection (UTI) testing, pneumonia testing, methicillin-resistant staphylococcus aureus (MRSA) testing, surgical site infection (SSI) testing, blood stream infection (BSI) testing, and others (GI, respiratory, bone, cardiovascular, etc.).By geography, the global hospital acquired disease testing market is spread across North America, Asia Pacific, Europe, and Rest of the World.By infection type, currently, the urinary tract infection testing segment leads the market and is expected to rise at an 18.1% CAGR for the forecast period. As such, the UTI segment will be valued at US$2.1 bn by 2019.

However, the SSI testing and pneumonia testing segments will also exhibit high demand from developing countries in Asia Pacific in the next few years. In this region, the growth of the hospital acquired disease testing market has been beneficial for progressive clinical research into the behavior of various pathogens. The increasing demand for reduced healthcare costs from both healthcare institutions and patients has been aiding growth of the hospital acquired disease testing market and its allied markets as well.

Some of the major companies operating in the global hospital acquired diseases testing market are Abbott Laboratories, Inc., Alere Inc., Cepheid Inc., Diatherix Laboratories Inc., Gen-Probe Inc., Nordion Inc., Qiagen GmbH, Becton Dickinson and Co., and bioMerieux Inc.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/hospital-acquired-disease-testing.htm

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Nachiket
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Media Relations Contact

Mr. Nachiket
Assistant Manager
Transparency Market Research
+1-518-618-1030
http://www.transparencymarketresearch.com/pressrelease/hospital-acquired-disease-testing.htm

View this press release online at: http://rwire.com/636918